A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer
NCT02897479
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Sarcomatoid Carcinoma
Interventions
DRUG:
Savolitinib
Sponsor
Hutchison Medipharma Limited